The role of erythropoietin therapy in the critically ill

Transfusion Medicine Reviews

Volumn 20, Issue 1, 2006, Pages 27-33

  Corwin, Howard L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; APLASIA; BLEEDING; BLOOD TRANSFUSION; BONE MARROW CELL; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; ERYTHROCYTE; HUMAN; INTENSIVE CARE UNIT; REVIEW; THROMBOEMBOLISM;

EID: 29144460986     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2005.08.002     Document Type: Article

References (42)

1. H.L. Corwin, A. Gettinger, and R.M. Rodriguez Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial Crit. Care Med. 27 1999 2346 2350
2. R.M. Rodriguez, H.L. Corwin, and A. Gettinger Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness J. Crit. Care 16 2001 36 41
3. H.L. Corwin, E. Abraham, and M.P. Fink Anemia and blood transfusion in the critically ill: Current clinical practice in the US-the CRIT study Crit. Care Med. 32 2004 39 52
4. B.R. Smoller, and M.S. Kruskall Phlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements N. Engl. J. Med. 314 1986 1233 1235
5. H.L. Corwin, K.C. Parsonnet, and A. Gettinger RBC transfusion in the ICU. Is there a reason? Chest 108 1995 767 771
6. E. Eyster, and J. Bernene Nosocomial anemia JAMA 223 1973 73 74
7. J. Tarpey, and P.G. Lawler Iatrogenic anaemia? A survey of venesection in patients in the intensive therapy unit Anaesthesia 45 1990 396 398
8. N. von Ahsen, C. Muller, and S. Serke Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients Crit. Care Med. 27 1999 2630 2639
9. J.L. Vincent, J.-F. Baron, and K. Reinhart Anemia and blood transfusion in critically ill patients JAMA 288 2002 1499 1507
10. J.F. Burnum Medical vampires N. Engl. J. Med. 314 1986 1250 1251
11. C.E. van Iperen, C.A.M. Gaillard, and R.J. Kraaijenhagen Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients Crit. Care Med. 28 2000 2773 2778
12. A. Gabriel, S. Kozek, and A. Chiari High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome J. Trauma 44 1998 361 367
13. S. Frede, J. Fandrey, and H. Pagel Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats Am. J. Physiol. 273 1997 R1067 R1071
14. W. Jelkmann Proinflammatory cytokines lowering erythropoietin production J. Interferon Cytokine Res. 18 1998 555 559
15. R.T. Means Jr., and S.B. Krantz Progress in understanding the pathogenesis of the anemia of chronic disease Blood 80 1992 1639 1647
16. S.B. Krantz Pathogenesis and treatment of the anemia of chronic disease Am. J. Med. Sci. 307 1994 353 359
17. H.L. Corwin, and S.B. Krantz Anemia of the critically ill: "Acute" anemia of chronic disease [editorial] Crit. Care Med. 28 2000 3098 3099
18. B. Littenberg, H. Corwin, and J. Leichter A practice guideline and decision aid for blood transfusion Immunohematology 11 1995 88 94
19. J.S. Groeger, K.K. Guntupalli, and M. Strosberg Descriptive analysis of critical care units in the United States: Patient characteristics and intensive care unit utilization Crit. Care Med. 21 1993 279 291
20. P.C. Hebert, G. Wells, and M.A. Blajchman A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care N. Engl. J. Med. 340 1999 409 417
21. K.A. Dietrich, S.A. Conrad, and C.A. Hebert Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated patients Crit. Care Med. 18 1990 940 944
22. J.A. Lorente, L. Landin, and R. De Pablo Effects of blood transfusion on oxygen transport variables in sepsis Crit. Care Med. 21 1993 1312 1318
23. P.E. Marik, and W.J. Sibbaid Effect of stored-blood transfusion on oxygen delivery in patients with sepsis JAMA 269 1993 3024 3029
24. R.D. Fitzgerald, C.M. Martin, and G.E. Dietz Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats Crit. Care Med. 25 1997 726 732
25. D.H. Henry, P. Bowers, and M.T. Romano Epoetin alfa: Clinical evolution of a pleiotropic cytokine Arch. Intern. Med. 164 2004 262 276
26. A. Gabriel, S. Kozek, and A. Chiari High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome J. Trauma 44 1998 361 367
27. H.L. Corwin, A. Gettinger, and R.G. Pearl Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial JAMA 288 2002 2827 2835
28. M. Silver, A. Bazan, and H.L. Corwin A randomized double blind placebo controlled trial of recombinant human erythropoietin in long term acute care patients Crit. Care Med. 31 2003 A167 (abstract, suppl)
29. K.-U. Eckardt, and N. Casadevall Pure red-cell aplasia due to antierythropoietin antibodies Nephrol. Dial. Transplant. 18 2003 865 869
30. S. Erbayraktar, O. Yilmaz, and N. Gokmen Erythropoietin is a multifactorial tissue-protective cytokine Curr. Hematol. Rep. 2 2003 465 470
31. D.S. Silverberg, D. Wexler, and M. Blurn The use of subcutaneous erythropoietin intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalization J. Am. Coll. Cardiol. 35 2000 1737 1744
32. H. Ehrenreich, M. Hasselblatt, and P. Lewczuk Erythropoietin treatment for acute stroke: A randomized double-blind proof-of-concept trial in man Stroke 33 2002 354
33. M.L. Brines, P. Ghezzi, and S. Keenan Erythropoietin crosses the blood brain barrier to protect against experimental brain injury Proc. Natl. Acad. Sci. U. S. A. 97 2000 10526 10531
34. X.Z. Liu, X.M. Xu, and R. Hu Neuronal and glial apoptosis after traumatic spinal cord injury J. Neurosci. 17 1997 5395 5406
35. T. Coleman, and M. Brines Recombinant human erythropoietin in critical illness: A role beyond anemia Crit. Care 8 2004 337 341
36. H.L. Corwin, and P. Hebert Avoiding a blood transfusion: How much is it worth? Crit. Care Med. 33 2005 672 674
37. K.M. Shermock, E. Horn, and P.A. Lipsett Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients Crit. Care Med. 33 2005 497 503
38. J.P. Aubuchon, J.D. Birkmeyer, and M.P. Busch Safety of the blood supply in the United States: Opportunities and controversies Ann. Intern. Med. 127 1997 904 909
39. J.L. Carson Should patients in intensive care units receive erythropoietin? JAMA 288 2002 2884 2886
40. H.G. Klein Will blood transfusion ever be safe enough? JAMA 284 2000 238 240
41. B.R. Jackson, M.P. Busch, and S.L. Stramer The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Transfusion 43 2003 721 729
42. H.L. Corwin, and J.P. Aubuchon Is leukoreduction of blood components for everyone? JAMA 289 2003 1993 1995